AUPH
Aurinia Pharmaceuticals Inc
NASDAQ: AUPH · HEALTHCARE · BIOTECHNOLOGY
$15.72
+3.22% today
Updated 2026-05-11
Market cap
$2.02B
P/E ratio
7.28
P/S ratio
6.78x
EPS (TTM)
$2.16
Dividend yield
—
52W range
$7 – $17
Volume
1.2M
Aurinia Pharmaceuticals Inc (AUPH) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
8 of 8
Last 8 quarters
Avg EPS surprise
+78.6%
Last 4 quarters
Revenue YoY growth
+24.4%
Most recent quarter
EPS YoY growth
+56.3%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+7.6%
Last 4 reports
Positive reaction rate
100%
4 of 4 quarters
Largest single-day move
+15.9%
2025-07-31
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-04-30 | $0.25 | +56.3% | $15.28 | $15.35 | +0.5% |
| 2026-03-04 | $1.53 | +898.0% | $14.15 | $14.74 | +4.2% |
| 2025-11-04 | $0.23 | +43.8% | $13.17 | $14.45 | +9.7% |
| 2025-07-31 | $0.16 | +14.3% | $9.05 | $10.49 | +15.9% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-03-31 | $0.16 | $0.25 | +56.3% | $77.70M | +24.4% |
| 2025-12-31 | $0.15 | $1.53 | +898.0% | $77.11M | +28.8% |
| 2025-09-30 | $0.16 | $0.23 | +43.8% | $73.47M | +8.4% |
| 2025-06-30 | $0.14 | $0.16 | +14.3% | $70.01M | +22.4% |
| 2025-03-31 | $0.10 | $0.16 | +60.0% | $62.47M | +24.2% |
| 2024-12-31 | $-0.02 | $0.01 | +162.5% | $59.87M | +32.8% |
| 2024-09-30 | $0.01 | $0.10 | +900.0% | $67.77M | +24.3% |
| 2024-06-30 | $0.01 | $0.01 | +0.0% | $57.19M | — |
| 2024-03-31 | $-0.14 | $-0.03 | +78.6% | $50.30M | — |
| 2023-12-31 | $-0.16 | $-0.19 | -18.8% | $45.09M | — |
| 2023-09-30 | $-0.17 | $-0.09 | +47.1% | $54.52M | — |
Frequently asked questions
Has Aurinia Pharmaceuticals Inc beaten earnings estimates?
Aurinia Pharmaceuticals Inc has beaten Wall Street EPS estimates in 8 of its last 8 quarterly reports, with an average EPS surprise of +78.6% over the last 4 quarters.
How does AUPH stock react to earnings?
AUPH stock has moved an average of +7.6% in the trading day following earnings over its last 4 reports, with positive reactions in 100% of those quarters.
What is Aurinia Pharmaceuticals Inc's revenue growth rate?
Aurinia Pharmaceuticals Inc reported year-over-year revenue growth of +24.4% in its most recent quarter, with EPS growing +56.3% year-over-year.